BridgeBio Pharma Inc.

NASDAQ: BBIO · Real-Time Price · USD
38.13
-0.23 (-0.60%)
At close: May 01, 2025, 3:21 PM

BridgeBio Pharma Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for BBIO stock have an median target of 50, with a low estimate of 45 and a high estimate of 72. The median target predicts an increase of 31.13% from the current stock price of 38.13.

Target Low Average Median High
Price $45 $53.3 $50 $72
Change 18.02% 39.78% 31.13% 88.83%

Latest Analyst Insight Report

Scotiabank maintains a Sector Outperform rating on... Unlock content with Pro Subscription

Updated Apr 30, 2025

Rating Oct 24Nov 24Dec 24Feb 25Mar 25Apr 25
Strong Buy 020102
Buy 422422
Hold 000000
Sell 000000
Strong Sell 000000
Total 4 4 2 5 2 4

Financial Forecast this Year

Revenue This Year
230.61M
from 221.9M
Increased by 3.9%
Revenue Next Year
530.7M
from 230.61M
Increased by 130.1%
EPS This Year
-3.74
from -2.88
Increased by -29.9%
EPS Next Year
-2.69
from -3.74
Increased by 28.1%